Andrew Tobin’s laboratory has two major interests. The first is in the action of drugs at G protein coupled receptors. In particular, how rational design might be applied to the design efficacious ligands to the muscarinic receptor family for the treatment of the symptoms and neurodegenerative disease and to slow disease progression. The other aspect of the Tobin laboratory focuses on targeting malaria parasite protein kinases with novel “bitopic” kinase inhibitors for the treatment of malaria. These projects underpin the activity of the Centre for Translational Pharmacology that Andrew has established together with Graeme Milligan at the University of Glasgow. Within the Centre Andrew brings his experience of running academic drug discovery from his time at the University of Leicester to conducting translational research at Glasgow aimed at moving basic research projects into drug discovery programmes.